Archives: Agenda

• How RTD cocktails are reshaping consumer habits
• Packaging innovations driving market success

Seedlip founder and game changer Ben Branson, takes on 10 quick fire questions from Jonathan Ford, co-founder of Pearlfisher and Rosalind Michaluk, Strategy Director at Pearlfisher — the creative force behind Seedlip’s iconic branding — to uncover what the past 10 years tells us about the next.

• Nootropics are the New Buzz: How brain-boosting ingredients are creating a white space for brands, and what makes nootropics different from other functional claims
• Bridging Science & Storytelling: Practical ways to educate consumers on complex ingredients without losing the ritual and fun of the drinking occasion
• From Ingredient to Icon: What it takes for a mind-enhancing beverage to stand out. Formulation, sourcing, regulatory guardrails, and flavour are all part of the brand promise
• Lessons from Kin: How we’ve navigated brand development, marketing, and community-building around cognitive function
• A Wellness Status Symbol: Why the next generation of drinkers sees cognitive wellness as the ultimate luxury, and how that shifts category strategy for innovators and suppliers alike
• Where We Go Next: What’s on the horizon for brands ready to push beyond mindful drinking into mind-bending territory

• Dives into GLP-1s and how this is changing beverage consumption
• It explores how GLP-1s are driving a shift from alcohol to soft drinks and how this impacts innovation
• Unpacks what innovation needs to look like for GLP-1 consumers – touching on hydration, greater functionality, taste innovation to deliver on consumer experiences

• Mapping out trial budgets to ensure financial feasibility throughout your study
• Securing VC funding through communication and forecasting budgets
• Strategies to avoid overspending by tracking finances during trials

• Utilizing trial budgets to increase efficiency between CROs and Sponsors
• Establishing trial expectations by conveying budget outlines effectively
• Ensuring your trial stays within budget throughout the full timeline

• Identifying and creating criteria that addresses exactly what your study needs to make the selection process easier
• Strengthening relationships with CROs by communicating effectively throughout your study
• Understanding and assessing CROs capabilities tailored to your specific trial needs to avoid running into roadblocks

The master protocol approach is transforming the landscape of drug development by allowing multiple treatments to be evaluated across different disease states or patient populations within a single trial structure. An approach like this can offer significant advantages, including increased efficiencies, faster decision-making and improved coordination but poses challenges to operationalization without the proper planning and support. ​In this session, explore the key aspects of master protocols, it’s benefits and challenges, and provide practical insights into implementation and operationalization.

Whether you are a researcher, clinician, or part of the pharma industry, this session will equip you with the knowledge to leverage master protocols effectively in your clinical research. ​

Key Takeaways: ​

• Understand the benefits, optimal use cases and best scenarios for master protocols. ​
• Maximize trial operations with improved coordination and more sub-study opportunities. ​
• Enhance data collection and sharing, broadening patient access to new therapies. ​
• Navigate strategic relationships for safe and successful master protocol research.